| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Thromboxane | 80 | 2011 | 122 | 4.810 |
Why?
|
| Blood Platelets | 76 | 2005 | 284 | 4.330 |
Why?
|
| Receptors, Prostaglandin | 53 | 1998 | 74 | 3.990 |
Why?
|
| Thromboxane A2 | 68 | 2011 | 88 | 3.130 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 30 | 2003 | 64 | 2.010 |
Why?
|
| Shock, Septic | 43 | 2015 | 101 | 1.910 |
Why?
|
| Thromboxane B2 | 61 | 2011 | 108 | 1.750 |
Why?
|
| Thromboxanes | 39 | 2002 | 53 | 1.750 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 38 | 1996 | 52 | 1.610 |
Why?
|
| Muscle, Smooth, Vascular | 23 | 2001 | 317 | 1.530 |
Why?
|
| Platelet Aggregation | 48 | 2005 | 127 | 1.300 |
Why?
|
| Prostaglandins H | 25 | 1994 | 32 | 1.300 |
Why?
|
| Testosterone | 12 | 2005 | 96 | 1.260 |
Why?
|
| MicroRNAs | 10 | 2022 | 447 | 1.230 |
Why?
|
| Endotoxins | 28 | 2008 | 76 | 1.200 |
Why?
|
| Fatty Acids, Unsaturated | 32 | 2003 | 84 | 1.190 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 37 | 2014 | 48 | 1.140 |
Why?
|
| Lipopolysaccharides | 31 | 2019 | 455 | 1.040 |
Why?
|
| Arachidonic Acids | 40 | 1995 | 97 | 1.000 |
Why?
|
| Sepsis | 10 | 2022 | 233 | 0.980 |
Why?
|
| Animals | 175 | 2022 | 20881 | 0.870 |
Why?
|
| Bridged Bicyclo Compounds | 18 | 1997 | 29 | 0.870 |
Why?
|
| Cardiovascular Diseases | 9 | 2018 | 940 | 0.770 |
Why?
|
| Rats | 87 | 2003 | 5300 | 0.760 |
Why?
|
| Thromboxane-A Synthase | 12 | 2011 | 24 | 0.750 |
Why?
|
| Aspirin | 13 | 2003 | 295 | 0.720 |
Why?
|
| Prostaglandin Endoperoxides | 12 | 1990 | 13 | 0.710 |
Why?
|
| Receptors, Cell Surface | 13 | 2005 | 248 | 0.690 |
Why?
|
| Epoprostenol | 22 | 2001 | 71 | 0.690 |
Why?
|
| Radioligand Assay | 27 | 2003 | 109 | 0.640 |
Why?
|
| Aorta | 14 | 2001 | 316 | 0.620 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 235 | 0.570 |
Why?
|
| In Vitro Techniques | 45 | 2003 | 765 | 0.570 |
Why?
|
| Pericytes | 5 | 2022 | 81 | 0.570 |
Why?
|
| Affinity Labels | 8 | 1998 | 66 | 0.570 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2011 | 138 | 0.570 |
Why?
|
| Protein Isoforms | 6 | 2011 | 246 | 0.560 |
Why?
|
| Macrophages, Peritoneal | 11 | 2012 | 67 | 0.550 |
Why?
|
| Prostaglandins | 19 | 1994 | 65 | 0.540 |
Why?
|
| Prostaglandins E | 28 | 1986 | 54 | 0.540 |
Why?
|
| SRS-A | 12 | 1991 | 20 | 0.520 |
Why?
|
| Macrophages | 28 | 2012 | 647 | 0.510 |
Why?
|
| Urinary Bladder | 13 | 1985 | 108 | 0.490 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 3 | 2022 | 106 | 0.490 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 24 | 2014 | 41 | 0.480 |
Why?
|
| Humans | 140 | 2022 | 68618 | 0.470 |
Why?
|
| Kinetics | 26 | 1998 | 1047 | 0.470 |
Why?
|
| GTP-Binding Proteins | 12 | 2006 | 231 | 0.470 |
Why?
|
| Amlodipine | 2 | 2005 | 31 | 0.460 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 27 | 1995 | 42 | 0.460 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 8 | 2003 | 73 | 0.450 |
Why?
|
| Social Support | 1 | 2016 | 423 | 0.450 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 7 | 2011 | 47 | 0.430 |
Why?
|
| Lung | 13 | 2021 | 849 | 0.410 |
Why?
|
| Iodine Radioisotopes | 18 | 2001 | 119 | 0.410 |
Why?
|
| Calcium | 18 | 2003 | 929 | 0.400 |
Why?
|
| Isoenzymes | 6 | 2003 | 308 | 0.400 |
Why?
|
| Cyclooxygenase Inhibitors | 11 | 2006 | 73 | 0.390 |
Why?
|
| Vasopressins | 10 | 1985 | 33 | 0.390 |
Why?
|
| Signal Transduction | 16 | 2020 | 2689 | 0.390 |
Why?
|
| Cells, Cultured | 30 | 2018 | 2673 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 15 | 2012 | 626 | 0.380 |
Why?
|
| Platelet Aggregation Inhibitors | 6 | 2003 | 373 | 0.380 |
Why?
|
| Receptors, Immunologic | 4 | 1991 | 72 | 0.360 |
Why?
|
| Cell Line | 12 | 2021 | 1752 | 0.350 |
Why?
|
| Male | 94 | 2020 | 37321 | 0.350 |
Why?
|
| Flutamide | 4 | 2005 | 10 | 0.340 |
Why?
|
| Arachidonic Acid | 29 | 1998 | 86 | 0.340 |
Why?
|
| Cyclooxygenase 1 | 3 | 2006 | 29 | 0.340 |
Why?
|
| Inflammation | 10 | 2019 | 1030 | 0.330 |
Why?
|
| Fatty Acids, Essential | 11 | 1990 | 16 | 0.330 |
Why?
|
| Staphylococcus aureus | 7 | 2007 | 175 | 0.330 |
Why?
|
| Cocaine-Related Disorders | 2 | 2005 | 504 | 0.320 |
Why?
|
| Mice | 28 | 2022 | 8474 | 0.320 |
Why?
|
| Endothelial Progenitor Cells | 2 | 2019 | 15 | 0.320 |
Why?
|
| Binding, Competitive | 15 | 1998 | 165 | 0.320 |
Why?
|
| Leukemia, Erythroblastic, Acute | 5 | 1996 | 15 | 0.320 |
Why?
|
| Calcium Channel Blockers | 3 | 2005 | 138 | 0.320 |
Why?
|
| Monocytes | 8 | 2006 | 210 | 0.310 |
Why?
|
| Prostaglandin H2 | 14 | 1994 | 16 | 0.310 |
Why?
|
| Hydrazines | 10 | 2003 | 23 | 0.310 |
Why?
|
| Imidazoles | 16 | 1986 | 175 | 0.300 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 508 | 0.300 |
Why?
|
| Blood Pressure | 15 | 2002 | 1451 | 0.300 |
Why?
|
| Diethyl Pyrocarbonate | 3 | 1997 | 4 | 0.300 |
Why?
|
| Indomethacin | 23 | 1996 | 107 | 0.290 |
Why?
|
| Cyclooxygenase 2 | 4 | 2006 | 160 | 0.290 |
Why?
|
| Castration | 2 | 2005 | 13 | 0.290 |
Why?
|
| Vasoconstrictor Agents | 6 | 2001 | 107 | 0.280 |
Why?
|
| Capillary Permeability | 7 | 2018 | 69 | 0.280 |
Why?
|
| Androgen Antagonists | 2 | 2005 | 45 | 0.280 |
Why?
|
| Biomedical Research | 2 | 2015 | 310 | 0.280 |
Why?
|
| Azides | 4 | 1990 | 56 | 0.280 |
Why?
|
| Hemodynamics | 13 | 1991 | 705 | 0.270 |
Why?
|
| Estradiol | 4 | 1995 | 176 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2006 | 240 | 0.270 |
Why?
|
| Salmonella enteritidis | 16 | 2001 | 24 | 0.260 |
Why?
|
| Endothelial Cells | 3 | 2020 | 384 | 0.260 |
Why?
|
| Membrane Proteins | 5 | 2006 | 617 | 0.260 |
Why?
|
| Dinoprost | 3 | 2003 | 27 | 0.260 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 1293 | 0.260 |
Why?
|
| Blood Vessels | 6 | 1989 | 102 | 0.250 |
Why?
|
| Fatty Acids, Monounsaturated | 4 | 1997 | 29 | 0.250 |
Why?
|
| Arrestins | 3 | 2011 | 92 | 0.240 |
Why?
|
| Tetrazoles | 7 | 1991 | 160 | 0.240 |
Why?
|
| Cytokines | 8 | 2020 | 866 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 11 | 2007 | 852 | 0.230 |
Why?
|
| Acetophenones | 6 | 1991 | 12 | 0.230 |
Why?
|
| Endotoxemia | 4 | 2012 | 27 | 0.220 |
Why?
|
| Ibuprofen | 8 | 1991 | 30 | 0.220 |
Why?
|
| Glomerular Mesangium | 3 | 2001 | 53 | 0.220 |
Why?
|
| Oleic Acids | 6 | 1989 | 40 | 0.220 |
Why?
|
| Diabetes Mellitus | 10 | 1985 | 694 | 0.220 |
Why?
|
| Cyclic AMP | 11 | 1998 | 223 | 0.220 |
Why?
|
| Blotting, Western | 9 | 2019 | 954 | 0.220 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 51 | 0.210 |
Why?
|
| Diabetic Angiopathies | 8 | 1985 | 203 | 0.210 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 4 | 2012 | 15 | 0.210 |
Why?
|
| Dicarboxylic Acids | 3 | 1991 | 16 | 0.210 |
Why?
|
| Kidney | 9 | 2011 | 945 | 0.210 |
Why?
|
| Headache | 1 | 2002 | 68 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2011 | 756 | 0.200 |
Why?
|
| Education, Graduate | 2 | 2015 | 30 | 0.200 |
Why?
|
| Drug Resistance | 2 | 2002 | 223 | 0.200 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 301 | 0.190 |
Why?
|
| Rats, Inbred Strains | 16 | 1998 | 532 | 0.190 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 2550 | 0.190 |
Why?
|
| Prostaglandin Antagonists | 4 | 1986 | 11 | 0.190 |
Why?
|
| Coronary Vessels | 4 | 2001 | 313 | 0.190 |
Why?
|
| RNA, Long Noncoding | 1 | 2022 | 54 | 0.190 |
Why?
|
| Mice, Knockout | 9 | 2022 | 1692 | 0.190 |
Why?
|
| Pulmonary Edema | 4 | 1989 | 37 | 0.190 |
Why?
|
| Exosomes | 2 | 2019 | 44 | 0.190 |
Why?
|
| Cell Membrane | 13 | 1998 | 525 | 0.190 |
Why?
|
| Leukotriene B4 | 4 | 1989 | 17 | 0.190 |
Why?
|
| Histidine | 2 | 1998 | 17 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2003 | 1745 | 0.180 |
Why?
|
| Dihydrotestosterone | 3 | 1997 | 13 | 0.180 |
Why?
|
| Bacterial Toxins | 3 | 1991 | 50 | 0.180 |
Why?
|
| Enterotoxins | 3 | 1991 | 40 | 0.180 |
Why?
|
| Flavonoids | 1 | 2001 | 109 | 0.180 |
Why?
|
| DNA, Complementary | 5 | 2003 | 251 | 0.180 |
Why?
|
| Circulating MicroRNA | 1 | 2020 | 9 | 0.180 |
Why?
|
| Chemokines | 3 | 2020 | 119 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 69 | 0.180 |
Why?
|
| Bridged-Ring Compounds | 2 | 1990 | 14 | 0.180 |
Why?
|
| Macrophage Activation | 4 | 2006 | 75 | 0.170 |
Why?
|
| 5-alpha Reductase Inhibitors | 2 | 1996 | 9 | 0.170 |
Why?
|
| Cardiovascular System | 2 | 2018 | 85 | 0.170 |
Why?
|
| Interleukin-6 | 5 | 2012 | 330 | 0.170 |
Why?
|
| Myocardial Infarction | 2 | 2018 | 807 | 0.170 |
Why?
|
| Sex Characteristics | 2 | 2003 | 295 | 0.170 |
Why?
|
| Anti-HIV Agents | 1 | 2001 | 135 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2014 | 234 | 0.170 |
Why?
|
| Caspase 1 | 1 | 2019 | 22 | 0.160 |
Why?
|
| Insulin | 6 | 1993 | 619 | 0.160 |
Why?
|
| Female | 45 | 2020 | 38074 | 0.160 |
Why?
|
| Bufo marinus | 14 | 1985 | 23 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2019 | 35 | 0.160 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 176 | 0.160 |
Why?
|
| Hypertension | 5 | 2018 | 1535 | 0.160 |
Why?
|
| Oxazoles | 2 | 2003 | 17 | 0.160 |
Why?
|
| Dogs | 14 | 1989 | 490 | 0.160 |
Why?
|
| Androstadienes | 2 | 2006 | 41 | 0.160 |
Why?
|
| Genetic Markers | 1 | 2018 | 144 | 0.160 |
Why?
|
| Drug Carriers | 1 | 2019 | 90 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2019 | 209 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2003 | 66 | 0.160 |
Why?
|
| Prostaglandin D2 | 4 | 2003 | 21 | 0.150 |
Why?
|
| Leukotrienes | 4 | 1993 | 13 | 0.150 |
Why?
|
| Muscle Contraction | 9 | 2001 | 210 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 282 | 0.150 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 659 | 0.150 |
Why?
|
| Radioimmunoassay | 9 | 2003 | 164 | 0.150 |
Why?
|
| Nitric Oxide | 7 | 2011 | 382 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2012 | 114 | 0.150 |
Why?
|
| Drug Tolerance | 15 | 2001 | 80 | 0.140 |
Why?
|
| Polyethylene Terephthalates | 1 | 1997 | 29 | 0.140 |
Why?
|
| Androgens | 1 | 1997 | 41 | 0.140 |
Why?
|
| Thiazolidinediones | 3 | 2003 | 77 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 5 | 2014 | 247 | 0.140 |
Why?
|
| Polytetrafluoroethylene | 1 | 1997 | 55 | 0.140 |
Why?
|
| Phosphorylation | 11 | 2014 | 1200 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 565 | 0.140 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 177 | 0.140 |
Why?
|
| NF-kappa B | 6 | 2020 | 432 | 0.140 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2012 | 34 | 0.140 |
Why?
|
| Androstenedione | 1 | 1996 | 7 | 0.130 |
Why?
|
| COS Cells | 4 | 2003 | 155 | 0.130 |
Why?
|
| Research Personnel | 1 | 2016 | 83 | 0.130 |
Why?
|
| Leukocyte Count | 3 | 1991 | 94 | 0.130 |
Why?
|
| Guanylate Cyclase | 1 | 1996 | 25 | 0.130 |
Why?
|
| Eicosanoids | 2 | 1993 | 16 | 0.130 |
Why?
|
| Spleen | 5 | 2011 | 301 | 0.130 |
Why?
|
| Guinea Pigs | 8 | 1997 | 124 | 0.130 |
Why?
|
| Dinoprostone | 5 | 1998 | 110 | 0.130 |
Why?
|
| Binding Sites | 6 | 2000 | 631 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 4 | 2005 | 492 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2019 | 254 | 0.130 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1997 | 182 | 0.130 |
Why?
|
| Anabolic Agents | 1 | 1995 | 6 | 0.130 |
Why?
|
| Saphenous Vein | 5 | 1990 | 61 | 0.130 |
Why?
|
| Endothelium, Vascular | 4 | 2019 | 371 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 6 | 2008 | 150 | 0.130 |
Why?
|
| Cecum | 4 | 2019 | 39 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 6 | 2008 | 147 | 0.130 |
Why?
|
| Biology | 1 | 2015 | 14 | 0.120 |
Why?
|
| I-kappa B Proteins | 4 | 2003 | 47 | 0.120 |
Why?
|
| Peptides | 4 | 2011 | 455 | 0.120 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1995 | 52 | 0.120 |
Why?
|
| Arteriosclerosis | 4 | 1983 | 137 | 0.120 |
Why?
|
| Urologic Neoplasms | 1 | 2014 | 14 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2011 | 1553 | 0.120 |
Why?
|
| Platelet Count | 7 | 1993 | 100 | 0.120 |
Why?
|
| Adult | 20 | 2015 | 21403 | 0.120 |
Why?
|
| Faculty | 1 | 2015 | 56 | 0.120 |
Why?
|
| Structure-Activity Relationship | 7 | 1995 | 420 | 0.120 |
Why?
|
| Body Water | 3 | 1984 | 35 | 0.120 |
Why?
|
| Cricetinae | 5 | 2001 | 262 | 0.120 |
Why?
|
| Gram-Positive Bacteria | 2 | 2005 | 23 | 0.120 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2014 | 21 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2019 | 223 | 0.120 |
Why?
|
| Peroxiredoxin VI | 1 | 2014 | 18 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2003 | 753 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 94 | 0.120 |
Why?
|
| Middle Aged | 14 | 2020 | 21147 | 0.120 |
Why?
|
| Solubility | 6 | 1996 | 134 | 0.110 |
Why?
|
| Heart Failure | 2 | 2018 | 1180 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2015 | 157 | 0.110 |
Why?
|
| Cycloheximide | 4 | 2001 | 50 | 0.110 |
Why?
|
| Arginine Vasopressin | 2 | 1983 | 16 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 194 | 0.110 |
Why?
|
| Iloprost | 2 | 1992 | 4 | 0.110 |
Why?
|
| Cloning, Molecular | 3 | 1999 | 357 | 0.110 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1993 | 21 | 0.110 |
Why?
|
| Xenopus Proteins | 1 | 1993 | 31 | 0.110 |
Why?
|
| Multiple Organ Failure | 2 | 2012 | 36 | 0.110 |
Why?
|
| Transfection | 5 | 2007 | 782 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2016 | 1342 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 1993 | 195 | 0.100 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 2 | 2003 | 4 | 0.100 |
Why?
|
| Prostanoic Acids | 6 | 1983 | 9 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2011 | 157 | 0.100 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 1989 | 9 | 0.100 |
Why?
|
| src-Family Kinases | 2 | 2003 | 91 | 0.100 |
Why?
|
| Pyrazoles | 3 | 2011 | 190 | 0.100 |
Why?
|
| Protein Kinase C | 2 | 2001 | 270 | 0.100 |
Why?
|
| Dactinomycin | 3 | 2000 | 31 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 48 | 0.100 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 34 | 0.100 |
Why?
|
| Swine | 5 | 1997 | 672 | 0.100 |
Why?
|
| Propranolol | 2 | 1990 | 103 | 0.100 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 11 | 1983 | 50 | 0.100 |
Why?
|
| ortho-Aminobenzoates | 2 | 1988 | 3 | 0.100 |
Why?
|
| Blood Coagulation | 4 | 1991 | 123 | 0.100 |
Why?
|
| Arthritis, Experimental | 1 | 2011 | 38 | 0.100 |
Why?
|
| Dihydropyridines | 1 | 1991 | 13 | 0.100 |
Why?
|
| Linseed Oil | 1 | 1991 | 2 | 0.100 |
Why?
|
| Calcium Channel Agonists | 1 | 1991 | 18 | 0.090 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1991 | 8 | 0.090 |
Why?
|
| Furosemide | 2 | 1982 | 45 | 0.090 |
Why?
|
| Pertussis Toxin | 6 | 2011 | 72 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 1993 | 202 | 0.090 |
Why?
|
| Renin | 4 | 1983 | 96 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 1995 | 618 | 0.090 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2011 | 46 | 0.090 |
Why?
|
| Prognosis | 4 | 2020 | 2093 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2014 | 268 | 0.090 |
Why?
|
| CHO Cells | 3 | 2001 | 161 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 1998 | 1447 | 0.090 |
Why?
|
| Vasoconstriction | 5 | 2001 | 81 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2014 | 506 | 0.090 |
Why?
|
| Drug Interactions | 5 | 2001 | 289 | 0.090 |
Why?
|
| Cell Movement | 4 | 2020 | 630 | 0.090 |
Why?
|
| Leukopenia | 4 | 1991 | 23 | 0.090 |
Why?
|
| Kallikreins | 4 | 1985 | 323 | 0.090 |
Why?
|
| Biomarkers | 4 | 2018 | 1593 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 507 | 0.090 |
Why?
|
| Ligation | 3 | 2019 | 83 | 0.090 |
Why?
|
| Theophylline | 3 | 1984 | 22 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 2 | 2003 | 208 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2011 | 141 | 0.090 |
Why?
|
| Peroxidase | 3 | 2019 | 40 | 0.090 |
Why?
|
| Hematocrit | 5 | 1991 | 70 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2014 | 718 | 0.090 |
Why?
|
| Calcimycin | 7 | 1993 | 32 | 0.090 |
Why?
|
| Extracellular Space | 2 | 1987 | 121 | 0.080 |
Why?
|
| Azoles | 2 | 1987 | 7 | 0.080 |
Why?
|
| Water | 2 | 1980 | 230 | 0.080 |
Why?
|
| Rabbits | 11 | 1994 | 509 | 0.080 |
Why?
|
| Lung Injury | 1 | 1989 | 38 | 0.080 |
Why?
|
| Carbazoles | 3 | 1996 | 46 | 0.080 |
Why?
|
| Problem Solving | 1 | 2009 | 36 | 0.080 |
Why?
|
| Second Messenger Systems | 3 | 1995 | 53 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 1033 | 0.080 |
Why?
|
| Lupus Nephritis | 1 | 2011 | 193 | 0.080 |
Why?
|
| Sodium | 4 | 1987 | 161 | 0.080 |
Why?
|
| Arachidonate Lipoxygenases | 1 | 1988 | 3 | 0.080 |
Why?
|
| Naphthoquinones | 1 | 1988 | 14 | 0.080 |
Why?
|
| Fatty Acids | 4 | 1991 | 222 | 0.080 |
Why?
|
| Purines | 3 | 2003 | 39 | 0.080 |
Why?
|
| Mentors | 1 | 2009 | 81 | 0.080 |
Why?
|
| Lung Diseases | 2 | 1987 | 175 | 0.080 |
Why?
|
| Attitude | 1 | 2009 | 121 | 0.080 |
Why?
|
| Epithelium | 7 | 1985 | 172 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 951 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 1990 | 211 | 0.080 |
Why?
|
| United States | 2 | 2011 | 7367 | 0.080 |
Why?
|
| Thiazoles | 3 | 2003 | 95 | 0.080 |
Why?
|
| Oxidoreductases | 3 | 1983 | 117 | 0.080 |
Why?
|
| Thrombocytopenia | 6 | 1991 | 122 | 0.080 |
Why?
|
| Tissue Extracts | 1 | 1987 | 10 | 0.070 |
Why?
|
| Cell Extracts | 1 | 1987 | 21 | 0.070 |
Why?
|
| Calcium Radioisotopes | 1 | 1987 | 4 | 0.070 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 86 | 0.070 |
Why?
|
| Peritoneal Cavity | 3 | 2010 | 25 | 0.070 |
Why?
|
| Liver | 5 | 2010 | 1118 | 0.070 |
Why?
|
| Interleukin-10 | 3 | 2014 | 144 | 0.070 |
Why?
|
| Streptococcus agalactiae | 1 | 2007 | 26 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 1989 | 163 | 0.070 |
Why?
|
| Immunoblotting | 3 | 1997 | 254 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 1994 | 1242 | 0.070 |
Why?
|
| Lysophospholipids | 1 | 2008 | 209 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2004 | 250 | 0.070 |
Why?
|
| Receptors, Leukotriene | 3 | 1991 | 8 | 0.070 |
Why?
|
| Thoracic Arteries | 1 | 1986 | 10 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2014 | 562 | 0.070 |
Why?
|
| Time Factors | 11 | 1996 | 4655 | 0.070 |
Why?
|
| Norepinephrine | 5 | 1996 | 276 | 0.070 |
Why?
|
| Mammary Arteries | 1 | 1986 | 18 | 0.070 |
Why?
|
| beta-Glucans | 1 | 2006 | 18 | 0.070 |
Why?
|
| Double-Blind Method | 3 | 2002 | 1738 | 0.070 |
Why?
|
| Prostaglandins F | 7 | 1983 | 13 | 0.070 |
Why?
|
| Phenoxybenzamine | 1 | 1986 | 7 | 0.070 |
Why?
|
| Adenosine Diphosphate | 8 | 1985 | 66 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 1993 | 1026 | 0.070 |
Why?
|
| Vasodilation | 3 | 2001 | 85 | 0.070 |
Why?
|
| Colchicine | 2 | 1985 | 48 | 0.070 |
Why?
|
| Haplotypes | 1 | 2006 | 174 | 0.070 |
Why?
|
| Pharmacogenetics | 1 | 2006 | 47 | 0.070 |
Why?
|
| beta-Arrestin 2 | 3 | 2011 | 29 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 1998 | 1083 | 0.070 |
Why?
|
| Sulindac | 1 | 1985 | 4 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2004 | 241 | 0.060 |
Why?
|
| beta-Arrestins | 3 | 2011 | 80 | 0.060 |
Why?
|
| Natriuresis | 2 | 1982 | 13 | 0.060 |
Why?
|
| Indenes | 1 | 1985 | 6 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 3 | 1985 | 43 | 0.060 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1985 | 13 | 0.060 |
Why?
|
| Phenethylamines | 1 | 1985 | 20 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 370 | 0.060 |
Why?
|
| Stimulation, Chemical | 5 | 2003 | 57 | 0.060 |
Why?
|
| Veins | 1 | 1985 | 68 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2001 | 2083 | 0.060 |
Why?
|
| Intracellular Fluid | 1 | 1984 | 24 | 0.060 |
Why?
|
| Dopamine | 5 | 1978 | 474 | 0.060 |
Why?
|
| Photolysis | 3 | 1990 | 16 | 0.060 |
Why?
|
| Body Fluids | 1 | 1984 | 41 | 0.060 |
Why?
|
| Kidney Glomerulus | 3 | 1993 | 155 | 0.060 |
Why?
|
| Substance Abuse Detection | 1 | 2005 | 66 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2005 | 1664 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 1 | 2004 | 61 | 0.060 |
Why?
|
| Patient Dropouts | 1 | 2005 | 98 | 0.060 |
Why?
|
| Oleic Acid | 4 | 1988 | 40 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2001 | 32 | 0.060 |
Why?
|
| Enzyme Activation | 5 | 2003 | 791 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 1985 | 82 | 0.060 |
Why?
|
| Thiazines | 1 | 1983 | 4 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2001 | 138 | 0.060 |
Why?
|
| Carboxylic Acids | 1 | 1983 | 24 | 0.060 |
Why?
|
| Verapamil | 1 | 1983 | 30 | 0.060 |
Why?
|
| Chromans | 1 | 2003 | 12 | 0.060 |
Why?
|
| Reference Values | 2 | 2003 | 579 | 0.060 |
Why?
|
| Streptococcus | 1 | 2003 | 15 | 0.060 |
Why?
|
| Ion Channels | 1 | 1983 | 72 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 2001 | 163 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2016 | 7029 | 0.050 |
Why?
|
| Gram-Negative Bacteria | 1 | 2003 | 55 | 0.050 |
Why?
|
| Blood Circulation | 2 | 1987 | 18 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 627 | 0.050 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2003 | 8 | 0.050 |
Why?
|
| Potassium Chloride | 2 | 1996 | 45 | 0.050 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1982 | 15 | 0.050 |
Why?
|
| Stereoisomerism | 4 | 1991 | 169 | 0.050 |
Why?
|
| Threonine | 1 | 2003 | 47 | 0.050 |
Why?
|
| Alanine | 1 | 2003 | 38 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 272 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 244 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2005 | 340 | 0.050 |
Why?
|
| Isoquinolines | 3 | 1991 | 37 | 0.050 |
Why?
|
| Cysteine | 1 | 2003 | 112 | 0.050 |
Why?
|
| Pain | 1 | 2006 | 472 | 0.050 |
Why?
|
| Poisson Distribution | 1 | 2002 | 85 | 0.050 |
Why?
|
| Glycine | 1 | 2003 | 89 | 0.050 |
Why?
|
| Hemoglobin Subunits | 1 | 2022 | 4 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2005 | 402 | 0.050 |
Why?
|
| Outpatients | 1 | 2002 | 127 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 3 | 2008 | 369 | 0.050 |
Why?
|
| Perfusion | 2 | 1994 | 131 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2001 | 86 | 0.050 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 1996 | 35 | 0.050 |
Why?
|
| Myocardium | 2 | 1983 | 1204 | 0.050 |
Why?
|
| Angiotensin II | 3 | 1996 | 220 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 1851 | 0.050 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2001 | 23 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 546 | 0.050 |
Why?
|
| Papaverine | 3 | 1989 | 10 | 0.050 |
Why?
|
| Blood Glucose | 7 | 1985 | 631 | 0.050 |
Why?
|
| Lipoproteins, HDL | 2 | 2016 | 113 | 0.050 |
Why?
|
| Polymyxin B | 2 | 1993 | 5 | 0.050 |
Why?
|
| Base Sequence | 2 | 2008 | 1015 | 0.050 |
Why?
|
| Survival Rate | 2 | 2019 | 1056 | 0.050 |
Why?
|
| Motivation | 1 | 2005 | 561 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 1991 | 57 | 0.050 |
Why?
|
| Cats | 5 | 1986 | 292 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1851 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 376 | 0.050 |
Why?
|
| Analysis of Variance | 4 | 2003 | 1040 | 0.050 |
Why?
|
| Okadaic Acid | 1 | 2000 | 22 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 12 | 0.050 |
Why?
|
| Progesterone | 1 | 2001 | 115 | 0.050 |
Why?
|
| Ganglia, Autonomic | 2 | 1978 | 10 | 0.050 |
Why?
|
| Comorbidity | 1 | 2005 | 1426 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 3 | 2011 | 118 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2001 | 411 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2021 | 102 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 191 | 0.040 |
Why?
|
| von Willebrand Factor | 5 | 1983 | 47 | 0.040 |
Why?
|
| Erythrocytes | 2 | 1990 | 137 | 0.040 |
Why?
|
| Cholesterol | 2 | 2016 | 331 | 0.040 |
Why?
|
| Microvessels | 1 | 2020 | 43 | 0.040 |
Why?
|
| Models, Animal | 1 | 2001 | 252 | 0.040 |
Why?
|
| Cocaine | 1 | 2005 | 555 | 0.040 |
Why?
|
| Gentamicins | 3 | 1985 | 68 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1070 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1979 | 31 | 0.040 |
Why?
|
| Virulence Factors, Bordetella | 3 | 2001 | 60 | 0.040 |
Why?
|
| Ligands | 2 | 1991 | 317 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 1980 | 200 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2021 | 237 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 266 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 532 | 0.040 |
Why?
|
| Risk Factors | 2 | 2016 | 5731 | 0.040 |
Why?
|
| Molecular Structure | 2 | 1991 | 397 | 0.040 |
Why?
|
| Escherichia coli K12 | 1 | 2019 | 9 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2019 | 23 | 0.040 |
Why?
|
| Leukotriene E4 | 3 | 1988 | 6 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1979 | 32 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2019 | 16 | 0.040 |
Why?
|
| Serum Albumin | 3 | 1990 | 104 | 0.040 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2019 | 21 | 0.040 |
Why?
|
| Neutrophils | 1 | 2020 | 204 | 0.040 |
Why?
|
| Lipoproteins, LDL | 2 | 2016 | 343 | 0.040 |
Why?
|
| Punctures | 1 | 2019 | 35 | 0.040 |
Why?
|
| Vitamin D-Binding Protein | 2 | 1989 | 58 | 0.040 |
Why?
|
| Pyroptosis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Fibroblasts | 5 | 2012 | 902 | 0.040 |
Why?
|
| Cytoplasm | 3 | 2014 | 155 | 0.040 |
Why?
|
| Thrombin | 2 | 1995 | 117 | 0.040 |
Why?
|
| Trachea | 1 | 2019 | 48 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1998 | 13 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 778 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 411 | 0.040 |
Why?
|
| Acetylglucosamine | 1 | 2019 | 46 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 2279 | 0.040 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 1998 | 10 | 0.040 |
Why?
|
| Neutropenia | 2 | 1991 | 72 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 1998 | 67 | 0.040 |
Why?
|
| Aged | 4 | 2014 | 14862 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
| Cholic Acids | 2 | 1990 | 8 | 0.040 |
Why?
|
| Epinephrine | 4 | 1985 | 103 | 0.040 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 2 | 1990 | 9 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1998 | 165 | 0.040 |
Why?
|
| Isomerism | 2 | 2003 | 63 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 231 | 0.040 |
Why?
|
| Actins | 2 | 1989 | 249 | 0.040 |
Why?
|
| Protein Binding | 3 | 2003 | 1027 | 0.040 |
Why?
|
| Bartter Syndrome | 1 | 1977 | 2 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 513 | 0.040 |
Why?
|
| Hyperaldosteronism | 1 | 1977 | 5 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 219 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 167 | 0.040 |
Why?
|
| Cell Division | 4 | 2008 | 541 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 4 | 2001 | 46 | 0.040 |
Why?
|
| Technetium | 2 | 1990 | 38 | 0.040 |
Why?
|
| Splanchnic Circulation | 2 | 1990 | 11 | 0.040 |
Why?
|
| Acid Phosphatase | 3 | 1983 | 36 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2010 | 714 | 0.040 |
Why?
|
| Species Specificity | 3 | 1989 | 303 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 1997 | 7 | 0.040 |
Why?
|
| RNA | 1 | 1998 | 171 | 0.040 |
Why?
|
| Carotid Arteries | 2 | 1997 | 110 | 0.040 |
Why?
|
| Wasp Venoms | 2 | 2011 | 8 | 0.040 |
Why?
|
| Methylprednisolone | 3 | 1987 | 99 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1989 | 358 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 1997 | 34 | 0.040 |
Why?
|
| Tunica Intima | 1 | 1997 | 59 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 1989 | 166 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1997 | 73 | 0.040 |
Why?
|
| Homeostasis | 2 | 2016 | 291 | 0.040 |
Why?
|
| Brain | 2 | 2022 | 2176 | 0.030 |
Why?
|
| Peritoneum | 2 | 1994 | 27 | 0.030 |
Why?
|
| Lipid A | 2 | 1993 | 9 | 0.030 |
Why?
|
| Kallidin | 3 | 1985 | 9 | 0.030 |
Why?
|
| Biological Transport | 4 | 1985 | 210 | 0.030 |
Why?
|
| Chlorides | 3 | 1985 | 68 | 0.030 |
Why?
|
| Ethanol | 1 | 2003 | 893 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 90 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 981 | 0.030 |
Why?
|
| Endothelium | 3 | 1986 | 98 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1994 | 73 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1982 | 756 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 682 | 0.030 |
Why?
|
| Cell Communication | 1 | 2016 | 116 | 0.030 |
Why?
|
| Leukemia, Myeloid | 1 | 1996 | 39 | 0.030 |
Why?
|
| Meclofenamic Acid | 3 | 1985 | 3 | 0.030 |
Why?
|
| Pregnancy | 3 | 1993 | 2334 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1996 | 42 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1998 | 306 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2011 | 146 | 0.030 |
Why?
|
| Spinal Cord | 2 | 1988 | 244 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1985 | 79 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1996 | 54 | 0.030 |
Why?
|
| Plasma | 1 | 2015 | 58 | 0.030 |
Why?
|
| Spinal Cord Injuries | 3 | 1988 | 551 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 1996 | 99 | 0.030 |
Why?
|
| Permeability | 2 | 1989 | 131 | 0.030 |
Why?
|
| Tobacco | 1 | 2016 | 161 | 0.030 |
Why?
|
| Hydroxylamine | 1 | 1995 | 9 | 0.030 |
Why?
|
| Hydroxylamines | 1 | 1995 | 20 | 0.030 |
Why?
|
| Colon | 3 | 1984 | 168 | 0.030 |
Why?
|
| Methacrylates | 2 | 1986 | 31 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 1995 | 18 | 0.030 |
Why?
|
| Pyridines | 2 | 2002 | 261 | 0.030 |
Why?
|
| Training Support | 1 | 2015 | 17 | 0.030 |
Why?
|
| Science | 1 | 2015 | 15 | 0.030 |
Why?
|
| Chromones | 2 | 2006 | 33 | 0.030 |
Why?
|
| Receptors, Angiotensin | 1 | 1995 | 59 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2015 | 29 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2001 | 284 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1995 | 45 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 2791 | 0.030 |
Why?
|
| Methyldopa | 1 | 1974 | 4 | 0.030 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Receptors, Epoprostenol | 2 | 1998 | 3 | 0.030 |
Why?
|
| Butadienes | 1 | 2014 | 26 | 0.030 |
Why?
|
| Morpholines | 2 | 2006 | 79 | 0.030 |
Why?
|
| Orchiectomy | 1 | 1994 | 25 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1996 | 324 | 0.030 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 567 | 0.030 |
Why?
|
| Glucans | 3 | 1990 | 12 | 0.030 |
Why?
|
| Toll-Like Receptors | 2 | 2005 | 56 | 0.030 |
Why?
|
| Zymosan | 2 | 2012 | 12 | 0.030 |
Why?
|
| Nitriles | 1 | 2014 | 68 | 0.030 |
Why?
|
| Arginine | 1 | 1995 | 102 | 0.030 |
Why?
|
| Kinins | 2 | 1985 | 109 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 47 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 1991 | 11 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1994 | 29 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1984 | 134 | 0.030 |
Why?
|
| Azasteroids | 1 | 1993 | 4 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2358 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2015 | 110 | 0.030 |
Why?
|
| Ureteral Obstruction | 1 | 1994 | 25 | 0.030 |
Why?
|
| Phosphates | 1 | 1994 | 72 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 149 | 0.030 |
Why?
|
| Myositis Ossificans | 3 | 1978 | 6 | 0.030 |
Why?
|
| Universities | 1 | 2015 | 191 | 0.030 |
Why?
|
| Lysosomes | 4 | 1983 | 136 | 0.030 |
Why?
|
| Fibrinolysis | 2 | 1983 | 55 | 0.030 |
Why?
|
| Cell Culture Techniques | 2 | 2006 | 189 | 0.030 |
Why?
|
| Data Collection | 1 | 2015 | 420 | 0.030 |
Why?
|
| Horses | 1 | 1993 | 20 | 0.030 |
Why?
|
| Alprostadil | 2 | 1983 | 20 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1993 | 62 | 0.030 |
Why?
|
| Lipopeptides | 1 | 2012 | 7 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 281 | 0.030 |
Why?
|
| Xanthine Oxidase | 2 | 1989 | 15 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2004 | 82 | 0.030 |
Why?
|
| Poly I-C | 1 | 2012 | 20 | 0.030 |
Why?
|
| Students | 1 | 2015 | 233 | 0.030 |
Why?
|
| Cell Separation | 1 | 1993 | 132 | 0.030 |
Why?
|
| Vascular Resistance | 3 | 1991 | 179 | 0.030 |
Why?
|
| Stem Cells | 1 | 2014 | 248 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2004 | 140 | 0.030 |
Why?
|
| Piperazines | 2 | 1991 | 206 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2004 | 134 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2007 | 1174 | 0.030 |
Why?
|
| Glucuronidase | 2 | 1983 | 11 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 1174 | 0.030 |
Why?
|
| Cell Survival | 2 | 1992 | 901 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2005 | 228 | 0.020 |
Why?
|
| Oxygen | 3 | 1988 | 386 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 1994 | 323 | 0.020 |
Why?
|
| Staurosporine | 1 | 1991 | 19 | 0.020 |
Why?
|
| Coronary Circulation | 2 | 1983 | 136 | 0.020 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 1991 | 2 | 0.020 |
Why?
|
| Bromosuccinimide | 1 | 1991 | 1 | 0.020 |
Why?
|
| beta-Arrestin 1 | 1 | 2011 | 22 | 0.020 |
Why?
|
| Benzophenones | 1 | 1991 | 12 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2001 | 28 | 0.020 |
Why?
|
| Lymphopenia | 1 | 1991 | 12 | 0.020 |
Why?
|
| Platelet Activation | 1 | 1991 | 24 | 0.020 |
Why?
|
| Camptothecin | 1 | 1991 | 39 | 0.020 |
Why?
|
| Peritonitis | 4 | 1985 | 46 | 0.020 |
Why?
|
| Blood Volume | 1 | 1991 | 47 | 0.020 |
Why?
|
| Platelet Adhesiveness | 3 | 1980 | 20 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 120 | 0.020 |
Why?
|
| Alkaloids | 1 | 1991 | 40 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 63 | 0.020 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1991 | 10 | 0.020 |
Why?
|
| Sex Factors | 1 | 1995 | 1266 | 0.020 |
Why?
|
| Fura-2 | 1 | 1991 | 21 | 0.020 |
Why?
|
| Muridae | 2 | 1981 | 9 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 1989 | 102 | 0.020 |
Why?
|
| Mesentery | 1 | 1991 | 17 | 0.020 |
Why?
|
| Cell Membrane Permeability | 3 | 1990 | 59 | 0.020 |
Why?
|
| Manganese | 1 | 1991 | 26 | 0.020 |
Why?
|
| Bacterial Load | 1 | 2011 | 24 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 53 | 0.020 |
Why?
|
| Nitrates | 1 | 2011 | 61 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1991 | 61 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1994 | 307 | 0.020 |
Why?
|
| Hypotension | 1 | 1991 | 74 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 41 | 0.020 |
Why?
|
| Indium Radioisotopes | 1 | 1990 | 19 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1991 | 181 | 0.020 |
Why?
|
| Isoproterenol | 2 | 1998 | 163 | 0.020 |
Why?
|
| Thionucleotides | 1 | 1990 | 21 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1990 | 30 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 1990 | 65 | 0.020 |
Why?
|
| Cell Count | 1 | 1991 | 248 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 696 | 0.020 |
Why?
|
| Diuresis | 2 | 1980 | 20 | 0.020 |
Why?
|
| Blood | 1 | 2010 | 40 | 0.020 |
Why?
|
| Collagen | 4 | 2003 | 636 | 0.020 |
Why?
|
| Serotonin | 2 | 2001 | 144 | 0.020 |
Why?
|
| Isoflurane | 1 | 1990 | 16 | 0.020 |
Why?
|
| Cardiac Output | 3 | 1991 | 133 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1990 | 150 | 0.020 |
Why?
|
| Detergents | 1 | 1990 | 34 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 235 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1991 | 133 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 274 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2001 | 201 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 1985 | 529 | 0.020 |
Why?
|
| Rats, Long-Evans | 2 | 2001 | 203 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1989 | 10 | 0.020 |
Why?
|
| Dehydroepiandrosterone | 1 | 1989 | 29 | 0.020 |
Why?
|
| Photochemistry | 1 | 1989 | 46 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1989 | 41 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1989 | 30 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 50 | 0.020 |
Why?
|
| DNA | 2 | 2002 | 597 | 0.020 |
Why?
|
| Prazosin | 1 | 1989 | 10 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 1989 | 63 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1989 | 117 | 0.020 |
Why?
|
| Obesity | 1 | 2016 | 1076 | 0.020 |
Why?
|
| Dibenzothiepins | 1 | 1988 | 1 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1989 | 42 | 0.020 |
Why?
|
| Dimercaprol | 1 | 1988 | 3 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 3 | 1985 | 87 | 0.020 |
Why?
|
| Catalase | 1 | 1988 | 85 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 1452 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 181 | 0.020 |
Why?
|
| Eicosanoic Acids | 2 | 1985 | 3 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2008 | 67 | 0.020 |
Why?
|
| South Carolina | 1 | 2015 | 2752 | 0.020 |
Why?
|
| Polymyxins | 1 | 1988 | 3 | 0.020 |
Why?
|
| Autoradiography | 2 | 2003 | 94 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 2005 | 475 | 0.020 |
Why?
|
| Inositol Phosphates | 2 | 2001 | 28 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 302 | 0.020 |
Why?
|
| Heptanoic Acids | 2 | 1994 | 28 | 0.020 |
Why?
|
| Trypsin Inhibitors | 1 | 1987 | 15 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2007 | 12 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1989 | 186 | 0.020 |
Why?
|
| Drug Resistance, Multiple | 1 | 2007 | 56 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 700 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 100 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3187 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2006 | 331 | 0.020 |
Why?
|
| Interleukins | 1 | 2007 | 79 | 0.020 |
Why?
|
| Mitochondria, Liver | 2 | 1983 | 148 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2007 | 140 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 710 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1987 | 117 | 0.020 |
Why?
|
| Pulmonary Circulation | 2 | 1988 | 79 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2006 | 35 | 0.020 |
Why?
|
| Cisplatin | 1 | 2007 | 192 | 0.020 |
Why?
|
| Lipoproteins | 2 | 1985 | 161 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1989 | 232 | 0.020 |
Why?
|
| Acrylates | 1 | 1986 | 17 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1986 | 13 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 597 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2006 | 103 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1987 | 248 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 1985 | 34 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2006 | 62 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2005 | 41 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 1985 | 27 | 0.020 |
Why?
|
| Prothrombin Time | 1 | 1985 | 24 | 0.020 |
Why?
|
| Tubulin | 1 | 1985 | 60 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 1 | 1985 | 57 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 1985 | 84 | 0.020 |
Why?
|
| Microtubules | 1 | 1985 | 104 | 0.020 |
Why?
|
| Carbon Isotopes | 3 | 1970 | 54 | 0.020 |
Why?
|
| Blood Substitutes | 1 | 1985 | 8 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 1989 | 1034 | 0.020 |
Why?
|
| Fibrinogen | 1 | 1985 | 87 | 0.020 |
Why?
|
| Chlortetracycline | 1 | 1984 | 1 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 1984 | 29 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 156 | 0.020 |
Why?
|
| Electrolytes | 1 | 1985 | 47 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 1984 | 14 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 332 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 1987 | 59 | 0.020 |
Why?
|
| Genotype | 1 | 2007 | 786 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1986 | 167 | 0.020 |
Why?
|
| Adolescent | 3 | 2014 | 8912 | 0.020 |
Why?
|
| Fluorescence | 1 | 1984 | 104 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2004 | 33 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1984 | 29 | 0.010 |
Why?
|
| Lipoproteins, IDL | 1 | 1983 | 8 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1983 | 19 | 0.010 |
Why?
|
| Lipoproteins, VLDL | 1 | 1983 | 32 | 0.010 |
Why?
|
| Densitometry | 1 | 2003 | 15 | 0.010 |
Why?
|
| Piroxicam | 1 | 1983 | 1 | 0.010 |
Why?
|
| Naproxen | 1 | 1983 | 3 | 0.010 |
Why?
|
| Gallopamil | 1 | 1983 | 1 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1983 | 49 | 0.010 |
Why?
|
| Capillaries | 1 | 1984 | 105 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1983 | 32 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1983 | 44 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 67 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 1983 | 112 | 0.010 |
Why?
|
| beta-Thromboglobulin | 1 | 1983 | 7 | 0.010 |
Why?
|
| Aminobenzoates | 1 | 1983 | 2 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2003 | 94 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 800 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1985 | 222 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2003 | 4 | 0.010 |
Why?
|
| Rolipram | 1 | 2003 | 9 | 0.010 |
Why?
|
| Hydronephrosis | 1 | 1983 | 12 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 1983 | 161 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2003 | 28 | 0.010 |
Why?
|
| Mice, Inbred NZB | 1 | 1982 | 37 | 0.010 |
Why?
|
| Adenylyl Cyclases | 2 | 1998 | 94 | 0.010 |
Why?
|
| Shock | 1 | 1983 | 28 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 5717 | 0.010 |
Why?
|
| Secretin | 1 | 1982 | 18 | 0.010 |
Why?
|
| Renal Circulation | 1 | 1982 | 49 | 0.010 |
Why?
|
| Sympathetic Nervous System | 2 | 1974 | 81 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 202 | 0.010 |
Why?
|
| Proteinuria | 1 | 1982 | 136 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1753 | 0.010 |
Why?
|
| Strontium Radioisotopes | 1 | 1982 | 4 | 0.010 |
Why?
|
| Vinblastine | 1 | 1982 | 40 | 0.010 |
Why?
|
| Inositol | 1 | 2001 | 11 | 0.010 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2001 | 9 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 1982 | 171 | 0.010 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2001 | 9 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1983 | 179 | 0.010 |
Why?
|
| Coronary Vasospasm | 1 | 2001 | 2 | 0.010 |
Why?
|
| Alcoholism | 1 | 1970 | 1109 | 0.010 |
Why?
|
| Microspheres | 1 | 1982 | 59 | 0.010 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2001 | 29 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2001 | 60 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 78 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2001 | 49 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1982 | 175 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2001 | 77 | 0.010 |
Why?
|
| Cyclopentanes | 1 | 2001 | 15 | 0.010 |
Why?
|
| Postmenopause | 1 | 2001 | 93 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2003 | 368 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1985 | 848 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1981 | 260 | 0.010 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1981 | 9 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2001 | 122 | 0.010 |
Why?
|
| Cricetulus | 1 | 2001 | 98 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1983 | 358 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 99 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2000 | 29 | 0.010 |
Why?
|
| Alkaline Phosphatase | 2 | 1977 | 71 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 629 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1980 | 160 | 0.010 |
Why?
|
| Prostaglandins D | 1 | 1980 | 2 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1982 | 296 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1980 | 61 | 0.010 |
Why?
|
| Peroxisomes | 1 | 2000 | 48 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 307 | 0.010 |
Why?
|
| alpha-Linolenic Acid | 1 | 1979 | 2 | 0.010 |
Why?
|
| Linolenic Acids | 1 | 1979 | 3 | 0.010 |
Why?
|
| Sciuridae | 1 | 1979 | 2 | 0.010 |
Why?
|
| Linoleic Acids | 1 | 1979 | 12 | 0.010 |
Why?
|
| Haplorhini | 1 | 1979 | 44 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1979 | 34 | 0.010 |
Why?
|
| Papio | 1 | 1979 | 27 | 0.010 |
Why?
|
| Bucladesine | 1 | 1978 | 8 | 0.010 |
Why?
|
| Dietary Fats | 1 | 1979 | 103 | 0.010 |
Why?
|
| Phospholipases | 1 | 1978 | 12 | 0.010 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1998 | 8 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 1998 | 12 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1998 | 189 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1998 | 119 | 0.010 |
Why?
|
| Aldosterone | 1 | 1977 | 51 | 0.010 |
Why?
|
| Acetaminophen | 1 | 1977 | 111 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 742 | 0.010 |
Why?
|
| Molsidomine | 1 | 1995 | 5 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 1995 | 13 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1995 | 14 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 23 | 0.010 |
Why?
|
| Thymidine | 1 | 1995 | 32 | 0.010 |
Why?
|
| Inbreeding | 1 | 1974 | 4 | 0.010 |
Why?
|
| Infant | 4 | 1989 | 2891 | 0.010 |
Why?
|
| Denervation | 1 | 1974 | 23 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1995 | 107 | 0.010 |
Why?
|
| Salmonella Infections, Animal | 1 | 1994 | 5 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1995 | 69 | 0.010 |
Why?
|
| Hormones | 1 | 1994 | 42 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1974 | 34 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1974 | 103 | 0.010 |
Why?
|
| Biological Assay | 1 | 1974 | 88 | 0.010 |
Why?
|
| Cattle | 1 | 1995 | 475 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1994 | 114 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 1994 | 184 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1974 | 206 | 0.010 |
Why?
|
| Sodium Fluoride | 1 | 1992 | 9 | 0.010 |
Why?
|
| Tritium | 1 | 1992 | 101 | 0.010 |
Why?
|
| Syndrome | 1 | 1991 | 255 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1970 | 13 | 0.010 |
Why?
|
| Codeine | 1 | 1970 | 1 | 0.010 |
Why?
|
| Dextropropoxyphene | 1 | 1970 | 1 | 0.010 |
Why?
|
| Morphine Dependence | 1 | 1970 | 4 | 0.010 |
Why?
|
| Child | 2 | 1983 | 6405 | 0.010 |
Why?
|
| Pressoreceptors | 1 | 1970 | 15 | 0.010 |
Why?
|
| Heart Septal Defects | 1 | 1989 | 27 | 0.010 |
Why?
|
| Phospholipids | 1 | 1989 | 108 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1968 | 52 | 0.010 |
Why?
|
| Free Radicals | 1 | 1988 | 65 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1989 | 238 | 0.000 |
Why?
|
| Etidronic Acid | 2 | 1978 | 3 | 0.000 |
Why?
|
| Esterases | 1 | 1987 | 9 | 0.000 |
Why?
|
| Immune Sera | 1 | 1987 | 30 | 0.000 |
Why?
|
| 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 1 | 1987 | 1 | 0.000 |
Why?
|
| Lung Compliance | 1 | 1987 | 10 | 0.000 |
Why?
|
| Golgi Apparatus | 2 | 1977 | 75 | 0.000 |
Why?
|
| Glutathione | 1 | 1988 | 343 | 0.000 |
Why?
|
| Organ Size | 1 | 1987 | 242 | 0.000 |
Why?
|
| Phospholipases A | 1 | 1986 | 41 | 0.000 |
Why?
|
| Edema | 1 | 1986 | 66 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1986 | 168 | 0.000 |
Why?
|
| Osmosis | 1 | 1985 | 38 | 0.000 |
Why?
|
| Skin | 2 | 1980 | 451 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 47 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1985 | 30 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1985 | 47 | 0.000 |
Why?
|
| Amiloride | 1 | 1985 | 22 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1985 | 67 | 0.000 |
Why?
|
| Diet, Sodium-Restricted | 1 | 1985 | 45 | 0.000 |
Why?
|
| Cations, Divalent | 1 | 1984 | 27 | 0.000 |
Why?
|
| Calmodulin | 1 | 1984 | 53 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1985 | 258 | 0.000 |
Why?
|
| Random Allocation | 1 | 1985 | 442 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1985 | 219 | 0.000 |
Why?
|
| Heart | 1 | 1968 | 850 | 0.000 |
Why?
|
| Hemoglobinometry | 1 | 1983 | 5 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1985 | 649 | 0.000 |
Why?
|
| Body Height | 1 | 1983 | 67 | 0.000 |
Why?
|
| Potassium | 1 | 1983 | 168 | 0.000 |
Why?
|
| Diet | 1 | 1986 | 514 | 0.000 |
Why?
|
| Posture | 1 | 1983 | 107 | 0.000 |
Why?
|
| Creatinine | 1 | 1983 | 243 | 0.000 |
Why?
|
| Ascitic Fluid | 1 | 1982 | 22 | 0.000 |
Why?
|
| Colloids | 1 | 1982 | 43 | 0.000 |
Why?
|
| Exercise Test | 1 | 1983 | 242 | 0.000 |
Why?
|
| Carbon | 1 | 1982 | 122 | 0.000 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1981 | 189 | 0.000 |
Why?
|
| Body Weight | 1 | 1983 | 554 | 0.000 |
Why?
|
| Heart Rate | 1 | 1983 | 568 | 0.000 |
Why?
|
| Prostaglandins E, Synthetic | 1 | 1980 | 5 | 0.000 |
Why?
|
| Phytohemagglutinins | 1 | 1980 | 16 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1983 | 601 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1981 | 383 | 0.000 |
Why?
|
| Alanine Transaminase | 1 | 1980 | 137 | 0.000 |
Why?
|
| Factor VIII | 1 | 1979 | 27 | 0.000 |
Why?
|
| Blood Coagulation Factors | 1 | 1979 | 44 | 0.000 |
Why?
|
| Arteries | 1 | 1979 | 108 | 0.000 |
Why?
|
| Secretory Rate | 1 | 1978 | 11 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1980 | 397 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1979 | 186 | 0.000 |
Why?
|
| Half-Life | 1 | 1977 | 96 | 0.000 |
Why?
|
| Cell Nucleolus | 1 | 1977 | 14 | 0.000 |
Why?
|
| Intercellular Junctions | 1 | 1977 | 32 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1985 | 3705 | 0.000 |
Why?
|
| Glycosaminoglycans | 1 | 1977 | 88 | 0.000 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1977 | 131 | 0.000 |
Why?
|
| Diabetic Retinopathy | 1 | 1976 | 110 | 0.000 |
Why?
|
| Phosphorus | 1 | 1974 | 64 | 0.000 |
Why?
|
| Diabetic Nephropathies | 1 | 1976 | 161 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1974 | 306 | 0.000 |
Why?
|
| Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 1970 | 2 | 0.000 |
Why?
|
| Tyramine | 1 | 1970 | 16 | 0.000 |
Why?
|
| Carotid Sinus | 1 | 1970 | 5 | 0.000 |
Why?
|
| Reflex | 1 | 1970 | 21 | 0.000 |
Why?
|